Product News: 04 2014

This month's featured products include Revision Skincare's Anti-Redness Essentials kit that incorporates 5 products to calm, hydrate, and protect the skin while providing antiaging benefits. Pierre Fabre Dermatologie obtains marketing authorization for the pediatric drug Hemangeol for proliferating infantile hemangioma requiring systemic therapy. Paladin Labs Inc receives US Food and Drug Administration approval of Impavido for leishmaniasis. Celgene Corporation receives approval for Otezla to treat adults with active psoriatic arthritis. Obagi Medical Products, Inc, a division of Valeant Pharmaceuticals North America LLC, adds 2 products to the Professional-C line. Pierre Fabre Dermo-Cosmétique USA introduces the Avène SOS Non-Ablative Post-Procedure Recovery Kit created for patients who have undergone nonablative laser, nonablative peel, or laser hair removal treatments. Xolair is approved for a new indication for the treatment of chronic idiopathic urticaria.